Danish pharmaceutical giant Novo Nordisk reported more soaring profits Thursday as it basks in the popularity of anti-diabetes and weight-loss drugs Ozempic and Wegovy which have turned it into Europe’s most valuable company.

Obsługiwane przez Wtyczka Echo RSS przez CodeRevolution.